Expanded EU footprint The company has announced expansions of facilities in Liverpool, UK, signaling growth in Europe and Northern Europe. This presents cross-sell opportunities for localized service, spare parts, and single-use product deployments across new regional operations.

Single-use focus Recent investments into a dedicated manufacturing facility for single-use products and a new Flexible Packaging division indicate heightened demand for disposable technologies. This creates upsell potential for single-use systems, transfer bags, and compatible accessories in life sciences and pharma manufacturing.

Robotic handling Launch of a robotic material handling solution enhances safety and efficiency in drug manufacturing. Prospects exist to pair robotic handling with fluid management systems for integrated aseptic transfer, bulk solids handling, and improved GMP-compliant workflows.

Aseptic expertise Specialization in powder and liquid transfer for biopharma and life sciences positions ChargePoint to target manufacturers migrating to closed or hybrid aseptic processes, offering optimized transfer vessels, containment, and intelligent storage solutions.

Quality and scale ISO9001 quality systems and a history of strategic acquisitions (Terracon) suggest reliability and growth potential. This supports selling into regulated environments requiring validated components, customization capabilities, and robust after-sales support.